White Papers

1. 2026 State Of Clinical Trial Technology: The Five Strategic Imperatives 3/12/2026

   AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

2. Best Practices In Rare Disease Patient Recruitment 3/9/2026

   Recruiting for rare disease clinical trials is daunting, and making patients aware of clinical trials, involving them in trial design, and building trust are a few ways sponsors can boost recruitment.

3. Offline eCOA: The Real-Time Monitoring Dilemma 3/9/2026

   Balance the need for offline data safety with the necessity of real-time monitoring. Learn how to navigate new regulatory requirements for source devices while maintaining high patient compliance.

4. Global e-Consent Matrix 3/9/2026

   Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.

5. Unlock The Power Of Clinical Data Science 3/9/2026

   Discover a unified, AI‑driven approach that helps clinical teams manage growing data complexity, accelerate insight generation, and improve trial oversight to enable faster decisions.

6. If Data Integrity Matters, Paper Is Not An Option 3/5/2026

   Ditch outdated paper assessments to ensure data integrity. Digital capture improves regulatory compliance, reduces administrative burden, and enhances the patient experience in clinical trials.

7. Real-Time Clinical Data Insights Delivered By Automation And AI 2/26/2026

   Automated data flows and human‑guided AI enable faster, more reliable oversight into clinical trials. Learn how real‑time insights and unified monitoring support quality, efficiency, and readiness.

8. Choosing The Right Platform: A Comparison For Regulated Industries 2/22/2026

   Regulated industries depend on tightly controlled review workflows, yet common tools rarely meet those demands. Explore how purpose‑built solutions strengthen compliance and help streamline timelines.

9. Managing Placebo Response To Improve Clinical Trial Success Rates 2/20/2026

   Many effective therapies fail in Phase 3 trials because high placebo response rates mask their true benefits. Successfully navigating this challenge requires a proactive, multi-pronged approach.

10. Biopharma Reaping Numerous Benefits From AI 2/18/2026

    Multiple AI use cases with significant impact have been identified, and they are expected to drive innovations in clinical trials, precision medicine, and commercial operations.